粟 發滿

Medicine & Life Sciences

1. Hepatocellular Carcinoma 100%
2. 15,16-dihydrotanshinone I 74%
3. Sorafenib 57%
4. Colonoscopes 52%
5. Hepatitis B virus 45%
6. Apoptosis 42%
7. osthol 39%
8. Peroxisome Proliferator-Activated Receptors 37%
9. Stomach 33%
10. Liver Cirrhosis 33%
11. Cyclin D 32%
12. Cell Proliferation 31%
13. Proteins 29%
14. Transforming Growth Factors 29%
15. WJ1376-1 29%
16. WJ1398-1 29%
17. Liver Neoplasms 28%
18. Helicobacter pylori 26%
19. Down-Regulation 25%
20. Metaplasia 25%
21. dibenzheptropine 25%
22. Neoplasms 25%
23. denbinobin 25%
24. human ATF3 protein 24%
25. Capsid 24%
26. Cholesterol 24%
27. Bacteremia 23%
28. Carcinoma 23%
29. Virion 22%
30. Duodenal Ulcer 21%
31. Colorectal Neoplasms 21%
32. 15-deoxy-delta(12,14)-prostaglandin J2 21%
33. Colonoscopy 20%
34. Capsule Endoscopes 20%
35. Enterococcus hirae 20%
36. Hydroxymethylglutaryl-CoA Synthase 20%
37. Adenocarcinoma 20%
38. Linitis Plastica 19%
39. Heterogeneous-Nuclear Ribonucleoprotein K 19%
40. Intubation 19%
41. Monocyte Chemoattractant Proteins 19%
42. Salvia miltiorrhiza 18%
43. Carbon Tetrachloride 18%
44. pyrrolidine 18%
45. glutaryl-coenzyme A 17%
46. Liver 17%
47. Endoscopic Hemostasis 17%
48. Cell Line 17%